Trial Outcomes & Findings for Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth (NCT NCT05120843)

NCT ID: NCT05120843

Last Updated: 2026-01-27

Results Overview

The study team will compare the number of potentially eligible participants to those who are screened for eligibility. The number screened will be defined as the number of people whose are reviewed to approach for enrollment. The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

13 participants

Primary outcome timeframe

Screening phase (Up to 1 week prior to enrollment)

Results posted on

2026-01-27

Participant Flow

We have included a Table for the screening and enrollment phase of the study because a major goal of the study was to assess feasibility of screening and enrollment procedures, as well as reasons for non-participation. This table, and the numbers included in this table, support calculation of Outcomes 1 - 3. In addition they provide important information about feasibility that are relevant to other research in this area.

Participant milestones

Participant milestones
Measure
Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
Screening and Enrollment Phase
STARTED
49
Screening and Enrollment Phase
Potentially Eligible on Chart Review
28
Screening and Enrollment Phase
Approached
28
Screening and Enrollment Phase
Confirmed Eligible
22
Screening and Enrollment Phase
Consented and Enrolled
13
Screening and Enrollment Phase
COMPLETED
13
Screening and Enrollment Phase
NOT COMPLETED
36
Intervention Phase
STARTED
13
Intervention Phase
COMPLETED
10
Intervention Phase
NOT COMPLETED
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
Screening and Enrollment Phase
Not eligible on chart review
21
Screening and Enrollment Phase
Not eligible on in-person screening
6
Screening and Enrollment Phase
Too much going on during hospital stay
3
Screening and Enrollment Phase
Perceived services not needed
2
Screening and Enrollment Phase
Recently moved to the area
1
Screening and Enrollment Phase
No reason given
3
Intervention Phase
Lost to Follow-up
3

Baseline Characteristics

Testing Feasibility of Care Coordination and Motivational Interviewing for Women With a Recent Preterm Birth

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
Age, Categorical
<=18 years
0 Participants
n=41 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
n=41 Participants
Age, Categorical
>=65 years
0 Participants
n=41 Participants
Age, Continuous
29.4 years
STANDARD_DEVIATION 5.8 • n=41 Participants
Sex: Female, Male
Female
13 Participants
n=41 Participants
Sex: Female, Male
Male
0 Participants
n=41 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=41 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
13 Participants
n=41 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=41 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=41 Participants
Race (NIH/OMB)
Asian
0 Participants
n=41 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=41 Participants
Race (NIH/OMB)
Black or African American
13 Participants
n=41 Participants
Race (NIH/OMB)
White
0 Participants
n=41 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=41 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=41 Participants
Region of Enrollment
United States
13 Participants
n=41 Participants
Gestational age at delivery
33.2 weeks
STANDARD_DEVIATION 3.0 • n=41 Participants

PRIMARY outcome

Timeframe: Screening phase (Up to 1 week prior to enrollment)

Population: See Participant Flow Section. The screening rate was 100% in that we were able to review all potentially eligible participants as defined here.

The study team will compare the number of potentially eligible participants to those who are screened for eligibility. The number screened will be defined as the number of people whose are reviewed to approach for enrollment. The number of potentially eligible participants will be considered the number of women with preterm births with Medicaid insurance.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=49 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Screening Rate (Feasibility)
49 Participants

PRIMARY outcome

Timeframe: Screening phase (Up to one week prior to enrollment)

Population: 22 patients were confirmed eligible of which 13 were consented.

The study team will track the proportion of eligible women approached for enrollment who enroll in the study.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=22 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Enrollment Rate (Feasibility)
13 Participants

PRIMARY outcome

Timeframe: Screening phase (Up to 1 week prior to enrollment)

Population: See also Participant Flow Section

For women who decline enrollment we will ask them, if they are willing, to provide reasons for non-participation and potential study modifications that might have encouraged them to participate. Responses will be tabulated and reviewed for potential themes.

Outcome measures

Outcome measures
Measure
Intervention Arm
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
n=9 Participants
This outcome involves people who declined to participate in this study
Reasons for Non-participation (Acceptability)
Recently moved to the area
1 people
Reasons for Non-participation (Acceptability)
No reason given
3 people
Reasons for Non-participation (Acceptability)
Too much going on during hospital stay
3 people
Reasons for Non-participation (Acceptability)
Perceived services not needed
2 people

PRIMARY outcome

Timeframe: Enrollment through six months

Population: We counted the participants who completed all study data assessments.

The study team will track the proportion of enrolled participants who complete the intervention and the study assessments.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Retention Rate (Feasibility)
9 Participants

PRIMARY outcome

Timeframe: Enrollment through six months

The study team will track the proportion of the baseline, 3-month, and 6-month assessments that are completed.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=39 Possible assessments
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Number of Completed Assessments (Feasibility)
31 Completed assessments

PRIMARY outcome

Timeframe: Enrollment through six months

Population: Though this was a pre-specified outcome, it was not properly defined prior to starting the pilot. Because this pilot approached intervention testing by delivering different components of the intervention to different individuals, we were unable to clarify the denominator for this measure. Data was not collected for this outcome measure due to a change in intervention delivery. Data for this outcome will not be collected or reported in the future.

We will assess the proportion of intervention components completed, including interventionist completion of screening tools, as well as other tasks outlined in the care plan, including focused education, navigation, and addressing barriers to care, screening.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: Enrollment through six months

Population: Data for this outcome measure was not collected. Motivational interviewing was planned to be recorded using the OnePass validated tool. This was a feasibility outcome measure which has since been determined to be not feasible because of unanticipated difficulty identifying appropriate conversations to record for analysis. The overall study status has been updated to 'Terminated' to reflect this absence of data. Data will not be collected or reported in the future.

OnePass is a validated tool used to evaluate MI practice and assess fidelity based on review of a single session, using 23 items to assess MI components.61 This tool yields a global score while also identifying specific areas for additional practice and training. Scores range from 1 - 7 with 5 considered a minimum for competence. Interventionists will complete at least one OnePass within a month of starting MI sessions with participants.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Baseline and 3 months

Autonomy support will be measured with the short form of the Health Care Climate Questionnaire (6 items, range 6 - 42, Cronbach alpha 0.82). Scores on the short form 6-item version are calculated by averaging the individual item scores. Higher average scores represent a higher level of perceived autonomy support.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=10 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Change in Autonomy Support
-2.5 units on a scale
Standard Error 11.1

SECONDARY outcome

Timeframe: Baseline and 6 months

Population: 7 participants provided complete data on this measure.

Autonomous motivation will be measured using the Autonomous Motivation and External Regulation scales of the Treatment Self-Regulation Questionnaire (10 items, range 7 - 70, Cronbach alpha 0.90) with a higher score indicating higher emotion regulation strategy.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=7 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Change in Autonomous Motivation
-1.1 units on a scale
Standard Deviation 9.9

SECONDARY outcome

Timeframe: 6 months

This will include postpartum visits, visits for contraceptive management, routine preventive care visits, and visits to follow-up on complications of pregnancy (secondary prevention). Visits will be abstracted from the health record and from interventionist records.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Count of Preventive Care Visits
2.2 visits
Standard Deviation 1.3

SECONDARY outcome

Timeframe: 6 months

This Outcome Measure reports the average percentage of the recommended care plan completed among participants. Recommended care will be abstracted from a care plan completed within the first two weeks after enrollment. Completed care will be abstracted from the health record and from interventionist records.

Outcome measures

Outcome measures
Measure
Intervention Arm
n=13 Participants
This intervention will combine care coordination and motivational interviewing strategies. Care coordination and motivational interviewing: Interventionist will engage participants in care planning, health education, health care navigation, screening for unmet health needs or social needs, and motivational interviewing. The final intervention is expected to be six months in duration. However during this single-arm open testing phase, some participants may receive only key components of the intervention in order to assess feasibility, reach, adoption, and fidelity of those components.
People Who Declined Participation
This outcome involves people who declined to participate in this study
Proportion of Recommended Care Completed
73 percentage
Standard Deviation 35

Adverse Events

Intervention Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Emily Gregory

Children's Hospital of Philadelphia

Phone: 2674251442

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place